Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|July 26, 2008
Validation of intraoperative risk assessment on frozen section for surgical management of endometrial carcinomaDaniel Egle, Barbara Grissemann, Alain G Zeimet, et al.
Anticancer Research|November 27, 2008
Activated p38-MAPK and gemcitabine sensitivity in recurrent ovarian cancerRenate Klotz, Alain Gustave Zeimet, Daniel Reimer, et al.
International Journal of Cancer|August 5, 2009
Infiltrating CD11b+CD11c+ cells have the potential to mediate inducible nitric oxide synthase-dependent cell death in mammary carcinomas of HER-2/neu transgenic miceNirmala Parajuli, Elisabeth Müller-Holzner, Günther Böck, et al.
The International Journal of Biological Markers|November 19, 2013
A standardized staining protocol for L1CAM on formalin-fixed, paraffin-embedded tissues using automated platformsMina Fogel, Ayelet Harari, Elisabeth Müller-Holzner, et al.
Cancer Letters|December 4, 2003
Human papillomavirus DNA in sera of cervical cancer patients as tumor markerAndreas Widschwendter, Anya Blassnig, Annemarie Wiedemair, et al.
American Journal of Obstetrics and Gynecology|November 18, 2004
Interferon-gamma expression is an independent prognostic factor in ovarian cancerChristian Marth, Heidi Fiegl, Alain G Zeimet, et al.
The International Journal of Developmental Biology|May 8, 2012
MMTV-neu mice deficient in STAT1 are susceptible to develop ovarian teratomasLára Hannesdóttir, Nina Daschil, Sonja Philipp, et al.
Breast Cancer Research and Treatment|January 12, 2011
Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patientsGeorg Göbel, Doris Auer, Inge Gaugg, et al.
Cancer Letters|May 26, 2004
A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancerHannes M Müller, Andreas Widschwendter, Heidi Fiegl, et al.
Pageof 5